We are live on ! Find out more
TB

Terril Brothers Portfolio holdings

AUM $388M
1-Year Est. Return 29.38%
This Fund
S&P 500
This Quarter Est. Return
+0.78%
1 Year Est. Return
+29.38%
3 Year Est. Return
+94.42%
5 Year Est. Return
+88.99%
10 Year Est. Return
+253.7%
AUM
$281M
AUM Growth
-$2.1M
Cap. Flow
-$3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
74.06%
Holding
47
New
4
Increased
13
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
PAGP icon
Plains GP Holdings
PAGP
+$7.34M
2
BHC icon
Bausch Health
BHC
+$1.41M
3
ALLY icon
Ally Financial
ALLY
+$1.33M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.07M
5
CEM
ClearBridge MLP and Midstream Fund Inc.
CEM
+$1.05M

Top Sells

Rank Stock Value
1
BIVV
Bioverativ Inc. Common Stock
BIVV
+$15.3M
2
AAPL icon
Apple
AAPL
+$398K
3
BAC icon
Bank of America
BAC
+$232K
4
MON
Monsanto Co
MON
+$191K
5
FAX
abrdn Asia-Pacific Income Fund
FAX
+$186K

Sector Composition

Rank Sector Weight
1 Financials 22.98%
2 Healthcare 16.95%
3 Technology 13.36%
4 Materials 11.41%
5 Energy 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEE icon
26
Ameren
AEE
$31.5B
$1.22M 0.43%
22,310
-90
-0.4% -$5K
XOM icon
27
ExxonMobil
XOM
$651B
$910K 0.32%
11,275
+435
+4% +$35.6K
IGSB icon
28
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$656K 0.23%
12,450
– –
USB icon
29
US Bancorp
USB
$99.6B
$631K 0.22%
12,150
-100
-0.8% -$5.15K
GILD icon
30
Gilead Sciences
GILD
$161B
$628K 0.22%
8,876
-81
-0.9% -$5.39K
NEO icon
31
NeoGenomics
NEO
$1.81B
$418K 0.15%
46,700
– –
SDS icon
32
ProShares UltraShort S&P500
SDS
$406M
$411K 0.15%
325
– –
IJH icon
33
iShares Core S&P Mid-Cap ETF
IJH
$123B
$357K 0.13%
+10,260
New +$354K
FFIN icon
34
First Financial Bankshares
FFIN
$4.97B
$354K 0.13%
16,000
– –
KO icon
35
Coca-Cola
KO
$354B
$352K 0.13%
7,846
– –
BKEP
36
DELISTED
Blueknight Energy Partners L.P.
BKEP
$349K 0.12%
55,900
– –
GLD icon
37
SPDR Gold Trust
GLD
$131B
$327K 0.12%
2,770
+6
+0.2% +$718
JASN
38
DELISTED
Jason Industries, Inc.
JASN
$316K 0.11%
245,182
-1,650
-0.7% -$2.21K
AON icon
39
Aon
AON
$77.3B
$312K 0.11%
+2,349
New +$297K
WBA
40
DELISTED
Walgreens Boots Alliance
WBA
$305K 0.11%
3,900
+1,000
+34% +$82.3K
EEM icon
41
iShares MSCI Emerging Markets ETF
EEM
$28B
$261K 0.09%
+6,304
New +$257K
GOOG icon
42
Alphabet (Google) Class C
GOOG
$3.9T
$215K 0.08%
4,740
-120
-2% -$5.49K
CVX icon
43
Chevron
CVX
$388B
$211K 0.08%
2,025
+104
+5% +$11K
GG
44
DELISTED
Goldcorp Inc
GG
$168K 0.06%
13,000
– –
JASNW
45
DELISTED
Jason Industries, Inc.
JASNW
$54K 0.02%
595,570
-1,900
-0.3% -$131
BIVV
46
DELISTED
Bioverativ Inc. Common Stock
BIVV
– –
-280,902
Closed -$15.3M
1
2

Similar funds

RWM
Ruedi Wealth Management Champaign, Illinois $388M AUM 14.69% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return
WA
WP Advisors San Francisco, California $387M AUM 21.17% 1-Year Est. Return
AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return

Terril Brothers's Q2 2017 Portfolio in Review

As of Q2 2017, Terril Brothers held 47 positions worth $281M, down 0.74% from $283M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Terril Brothers's Q2 2017 filing shows 4 new, 13 increased, 16 reduced and 1 closed positions. Its largest new stake was Bausch Health: 117,350 shares worth $2.03M. The largest sale was Bioverativ Inc. Common Stock, an estimated $15.3M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.

  • Terril Brothers's largest Q2 2017 buy was Bausch Health: 117,350 shares worth $2.03M.
  • Terril Brothers added most to Plains GP Holdings in Q2 2017, an estimated $7.34M increase.
  • Terril Brothers's biggest Q2 2017 reduction was Apple, cutting an estimated $398K.
  • Terril Brothers fully exited Bioverativ Inc. Common Stock in Q2 2017, selling an estimated $15.3M.
  • Terril Brothers's ten largest holdings make up 74% of its $281M portfolio in Q2 2017.
  • Terril Brothers opened 4 new positions and closed 1 in Q2 2017.
  • Terril Brothers's portfolio value fell 0.74% quarter-over-quarter to $281M.

Based on Terril Brothers's 13F filing for Q2 2017, filed 27 Jul 2017.